BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10024582)

  • 41. A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality.
    Solorzano CC; Ksontini R; Pruitt JH; Auffenberg T; Tannahill C; Galardy RE; Schultz GP; MacKay SL; Copeland EM; Moldawer LL
    Shock; 1997 Jun; 7(6):427-31. PubMed ID: 9185243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-Endotoxin 9-Meric Peptide with Therapeutic Potential for the Treatment of Endotoxemia.
    Krishnan M; Choi J; Choi S; Kim Y
    J Microbiol Biotechnol; 2021 Jan; 31(1):25-32. PubMed ID: 33263333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice.
    Murakami T; Obata T; Kuwahara-Arai K; Tamura H; Hiramatsu K; Nagaoka I
    Int Immunol; 2009 Aug; 21(8):905-12. PubMed ID: 19556302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A synthetic lipopolysaccharide-binding peptide based on the neutrophil-derived protein CAP37 prevents endotoxin-induced responses in conscious rats.
    Brackett DJ; Lerner MR; Lacquement MA; He R; Pereira HA
    Infect Immun; 1997 Jul; 65(7):2803-11. PubMed ID: 9199453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Annexin A5 binds to lipopolysaccharide and reduces its endotoxin activity.
    Rand JH; Wu XX; Lin EY; Griffel A; Gialanella P; McKitrick JC
    mBio; 2012; 3(2):. PubMed ID: 22415004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
    Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
    Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Kamysz W; Rocchi M; D'Amato G; Mocchegiani F; Silvestri C; Łukasiak J; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):207-16. PubMed ID: 15629532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lactoferrin protects against lipopolysaccharide-induced acute lung injury in mice.
    Li XJ; Liu DP; Chen HL; Pan XH; Kong QY; Pang QF
    Int Immunopharmacol; 2012 Feb; 12(2):460-4. PubMed ID: 22251871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flavonoids protect mice from two types of lethal shock induced by endotoxin.
    Takahashi K; Morikawa A; Kato Y; Sugiyama T; Koide N; Mu MM; Yoshida T; Yokochi T
    FEMS Immunol Med Microbiol; 2001 Jul; 31(1):29-33. PubMed ID: 11476978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
    Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Orlando F; Silvestri C; Bozzi A; Di Giulio A; Luzi C; Mangoni ML; Barra D; Saba V; Scalise G; Rinaldi AC
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2478-86. PubMed ID: 16801429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock.
    Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; D'Amato G; Circo R; Orlando F; Skerlavaj B; Silvestri C; Saba V; Zanetti M; Scalise G
    Am J Respir Crit Care Med; 2004 Jan; 169(2):187-94. PubMed ID: 14563656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biological characterization of endotoxins released from antibiotic-treated Pseudomonas aeruginosa and Escherichia coli.
    Kirikae T; Kirikae F; Saito S; Tominaga K; Tamura H; Uemura Y; Yokochi T; Nakano M
    Antimicrob Agents Chemother; 1998 May; 42(5):1015-21. PubMed ID: 9593119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus anti-lipopolysaccharide factor.
    Ried C; Wahl C; Miethke T; Wellnhofer G; Landgraf C; Schneider-Mergener J; Hoess A
    J Biol Chem; 1996 Nov; 271(45):28120-7. PubMed ID: 8910426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitory effects of dimethylacetyl-beta-cyclodextrin on lipopolysaccharide-induced macrophage activation and endotoxin shock in mice.
    Arima H; Motoyama K; Matsukawa A; Nishimoto Y; Hirayama F; Uekama K
    Biochem Pharmacol; 2005 Nov; 70(10):1506-17. PubMed ID: 16214116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modification of tumor necrosis factor-induced acute toxicity D-galactosamine challenge by polymyxin B, an anti-endotoxin.
    Sakaguchi S; Furusawa S; Yokota K; Takayanagi M; Takayanagi Y
    Int J Immunopharmacol; 2000 Nov; 22(11):935-42. PubMed ID: 11090702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum.
    Smith SR; Calzetta A; Bankowski J; Kenworthy-Bott L; Terminelli C
    J Leukoc Biol; 1993 Jul; 54(1):23-9. PubMed ID: 8336076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preventive effect of recombinant human lactoferrin on lipopolysaccharide-induced preterm delivery in mice.
    Sasaki Y; Otsuki K; Hasegawa A; Sawada M; Chiba H; Negishi M; Nagatsuka M; Okai T
    Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1035-8. PubMed ID: 15488117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice.
    Griffiths EA; Duffy LC; Schanbacher FL; Qiao H; Dryja D; Leavens A; Rossman J; Rich G; Dirienzo D; Ogra PL
    Dig Dis Sci; 2004 Apr; 49(4):579-89. PubMed ID: 15185861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparable endotoxic properties of lipopolysaccharides are manifest in diverse clinical isolates of gram-negative bacteria.
    Luchi M; Morrison DC
    Infect Immun; 2000 Apr; 68(4):1899-904. PubMed ID: 10722580
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock.
    Hwang YH; Park BK; Lim JH; Kim MS; Park SC; Hwang MH; Yun HI
    Eur J Pharmacol; 2007 Feb; 556(1-3):166-71. PubMed ID: 17126323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.